| ¿µ¹® | gland | ÇÑ±Û | »ù |
|---|---|---|---|
| ¼³¸í | ÀÚ½ÅÀÇ ´ë»ó¿¡ Çʿ䰡 ¾ø´Â ¹°ÁúÀ» ¸¸µé¾î ºÐºñÇÏ´Â ¼¼Æ÷°¡ ¸ð¿©¼ ¸¸µå´Â ±¸Á¶. Áï ºÐºñ¹°À» Á¦Á¶ÇÏ´Â ¼¼Æ÷°¡ ¸ðÀÎ °ÍÀÌ´Ù. ¼±¿¡´Â ³»ºÐºñ»ù°ú ¿ÜºÐºñ»ùÀÇ 2°¡Áö°¡ ÀÖ´Ù. ³»ºÐºñ»ùÀ̶õ ¸ö¹ÛÀÌ ¾Æ´Ñ ³»ºÎ, Áï Á÷Á¢ Ç÷ÁßÀ¸·Î ºÐºñ¹°À» ºÐºñÇÏ´Â »ùÀ¸·Î ÀÌ ¶§¿¡ ºÐºñµÇ´Â ¹°ÁúÀ» È£¸£¸óÀ̶ó°í ÇÑ´Ù. À̰ÍÀº ÁÖ·Î ¸ö¾ÈÀÇ ´Ù¸¥ ¼¼Æ÷¿¡ ÀÛ¿ëÀ» ÇÏ¿© ±× ¼¼Æ÷ÀÇ ´ë»ç, ºÐ¿ µîÀÇ º¯È¸¦ ÃÊ·¡ÇÏ°í ¸öÀÇ È¯°æÀÇ º¯È¿¡ µû¸¥ ÀûÀÀÀ» µ½´Â ¿ªÇÒÀ» ÇÑ´Ù. ¿ÜºÐºñ»ùÀ̶õ ¸ö¹ÛÀ¸·Î °ü±¸Á¶¸¦ ÅëÇÏ¿© ºÐºñ¹°À» ³»º¸³»´Â »ùÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | pineal gland | ÇÑ±Û | ¼Ö¹æ¿ï»ù, ¼Û°ú¼± |
|---|---|---|---|
| ¼³¸í | ³úÀÇ Áß¾Ó¼±ºÎÀ§ÀÇ µîÂÊ¿¡ Á¸ÀçÇÏ´Â ³»ºÐºñ±â°üÀÌ´Ù. ¼Ö¹æ¿ï»ùÀº melatoninÀ» ºÐºñÇÑ´Ù. µ¿¹°¿¡¼´Â ¼ººÐȹߴ޿¡ ±â¿©ÇÏ´Â °ÍÀ¸·Î µÇ¾î ÀÖÀ¸³ª, »ç¶÷¿¡¼´Â ±× ±â´ÉÀÌ ¾ÆÁ÷ ¸íȮġ ¾Ê´Ù. |
||
| ¿µ¹® | prostate gland | ÇÑ±Û | Àü¸³»ù |
|---|---|---|---|
| ¼³¸í | ³²¼º»ý½Ä±âÀÇ ¿ÜºÐºñ»ùÀÇ ÀÏÁ¾À¸·Î, ¹æ±¤ÀÇ ¸ñºÎºÐ°ú ¿äµµ¸¦ µÑ·¯½Î°í ÀÖ´Ù. Àü¸³»ùÀº Á¤¾×À» ¸¸µå´Â Àü¸³»ù¾×À» ºÐºñÇϸç 5°³ÀÇ ¿±À¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | salivary gland | ÇÑ±Û | ħ»ù, Ÿ¾×¼± |
|---|---|---|---|
| ¼³¸í | ÀÔ ¼ÓÀ¸·Î ħÀ» ºÐºñÇÏ´Â ¿ÜºÐºñ»ùÀ¸·Î ÀÎü¿¡´Â ¼¼ ½ÖÀÇ Ä§»ùÀÌ Àִµ¥ ±Í¹Ø»ù, Åιػù ¹× Çô¹Ø»ùÀÌ ±×µéÀÌ´Ù. ħ»ùÀº ºÐ·ù»óÀ¸·Î ¼Òȱâ°èÅëÀÇ ÇÑ Àå±âÀ̸ç, ¼ÒȰüÀÇ ÇÑ ºÎ¼Ó»ùÀ¸·Î ±¸ºÐµÈ´Ù. Çô¹Ø»ùÀº ±× ¿Ü ±¸° Á¡¸· ³»¿¡ »êÀçÇϰí ÀÖ´Â ¼ö¸¹Àº ÀÛÀº ħ»ù°ú °°ÀÌ ¹±Àº ¿ë¾×À» ²÷ÀÓ¾øÀÌ ºÐºñÇϰí ÀÖÁö¸¸, ±Í¹Ø»ù°ú ÅιػùÀº ÀÚ±ØÀ» ¹ÞÀ» ¶§¸¸ ħÀ» ºÐºñÇÑ´Ù. |
||
| ¿µ¹® | sebaceous gland | ÇÑ±Û | ÇǺα⸧»ù |
|---|---|---|---|
| ¼³¸í | ÇǺÎÀÇ ÇÇÇÏÁ¶Á÷¿¡ ÀÖ´Â ¿ÂºÐºñ»ù(holocrine gland)À¸·Î ÇǺΠ±â¸§À̳ª, ±× ¿Ü ±â¸§ ¼ººÐÀ» ºÐºñÇÑ´Ù. |
||
| AES | acetone-extracted serum; American Electroencephalographic Society; American Encephalographic Society... |
|---|---|
| EC | effective concentration; ejection click; electrochemical; electron capture; embryonal carcinoma; eme... |
| E&M | endocrine and metabolic |
| Endo | endocardial, endocardium; endocrine, endocrinology; endodontics; endotracheal |
| FMEN | familial multiple endocrine neoplasia |
| endocrine | Pertaining to internal secretions, hormonal. Compare: exocrine. Origin: Gr. Krinein = to separate (18 Nov 1997) |
|---|---|
| endocrine cells of gut | Cells found throughout the lining of the gastrointestinal tract that contain regulatory peptide hormones and/or biogenic amines. The substances are located in secretory granules and act in an endocrine or paracrine manner. Some of these substances are also found in neurons in the gut. There are at least 15 different types of endocrine cells of the gut. Some take up amine precursors and have been called apud cells. However, most endocrine cells of the gut apparently have endodermal rather than neuroectodermal origin, so the relationship with apud cells is not clear. (12 Dec 1998) |
| endocrine disorders | Disorders which involve the over-production or under-production of hormone substances from an endocrine gland. Some examples include diabetes, hypothyroidism, hyperthyroidism, hyperparathyroidism, Cushing's disease, Cushing's syndrome and acromegaly. (27 Sep 1997) |
| endocrine exophthalmos | Exophthalmos associated with thyroid gland disorders. See: Graves' ophthalmopathy, Graves' orbitopathy. (05 Mar 2000) |
| endocrine glands | Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions. (12 Dec 1998) |
| endocrine hormones | Hormones produced by the endocrine system. Compare: tissue hormones. (05 Mar 2000) |
| endocrine manipulation | Treating breast cancer by changing the hormonal balance of the body to prevent hormone dependent cancer cells from multiplying. (09 Oct 1997) |
| endocrine ophthalmopathy | Exophthalmos caused by increased water content of retro-ocular orbital tissues; associated with thyroid disease, usually hyperthyroidism. Synonym: endocrine ophthalmopathy, Graves' orbitopathy. (05 Mar 2000) |
| endocrine surgical procedures | Surgery performed on any endocrine gland. (12 Dec 1998) |
| endocrine system | The system of glands that release their secretions (hormones) directly into the circulatory system. In addition to the endocrine glands, included are the chromaffin system and the neurosecretory systems. (12 Dec 1998) |
| tuberculosis, endocrine | Tuberculous infection of the endocrine glands. (12 Dec 1998) |
| familial multiple endocrine adenomatosis | The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance. Synonym: multiple endocrine adenomatosis. (05 Mar 2000) |
| bladder neoplasms | Cancers or tumours of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric. (12 Dec 1998) |
| bone marrow neoplasms | Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as myeloma. most bone marrow neoplasms are metastatic. (12 Dec 1998) |
| breast neoplasms, male | Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Two-thirds of patients present with intraductal carcinoma. The average age of onset is 60 years for men. Orchiectomy was the standard treatment but it has been replaced by tamoxifen as the initial therapy since oestrogen-receptor-positive tumours are predominant in males. Orchiectomy and mastectomy may be used if initial drug therapy is not successful. The prognosis is worse than that for females. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|